APA (7th ed.) Citation

Adra, N., Einhorn, L. H., Althouse, S. K., Ammakkanavar, N. R., Musapatika, D., Albany, C., . . . Hanna, N. H. (2018). Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: A Hoosier Cancer Research Network Study GU14-206. Annals of Oncology, 29(1), 209. https://doi.org/10.1093/annonc/mdx680

Chicago Style (17th ed.) Citation

Adra, N., L H. Einhorn, S K. Althouse, N R. Ammakkanavar, D. Musapatika, C. Albany, D. Vaughn, and N H. Hanna. "Phase II Trial of Pembrolizumab in Patients with Platinum Refractory Germ-cell Tumors: A Hoosier Cancer Research Network Study GU14-206." Annals of Oncology 29, no. 1 (2018): 209. https://doi.org/10.1093/annonc/mdx680.

MLA (9th ed.) Citation

Adra, N., et al. "Phase II Trial of Pembrolizumab in Patients with Platinum Refractory Germ-cell Tumors: A Hoosier Cancer Research Network Study GU14-206." Annals of Oncology, vol. 29, no. 1, 2018, p. 209, https://doi.org/10.1093/annonc/mdx680.